Home - Tandem Meetings News

February 5, 2026

Session to look at heterogeneity of hematopoietic stem cells behind cell therapy

Chair Christopher Hourigan, DM, DPhil, FRCP, discusses the potential for better understanding the diversity of cells that make HSC transplant successful.
February 5, 2026

Joint plenary session marks successes and challenges of cell therapy landscape

Speakers highlight real-world success in increasing treatments and note possible solutions for obstacles ahead.

MORE #TANDEM26 NEWS

February 5, 2026

Experts highlight the use of iPSC for transplant and gene therapy

Speakers detail novel studies and methods to reduce the need for patient- or donor-derived cells.
February 5, 2026

Panel to explore benefits and barriers of AI in cellular therapy

Panelist Wasay Khan, MD, PhD, explains why integrating artificial intelligence comes with hurdles.
February 5, 2026

Session to discuss the unique toxicities associated with CAR T

Chair Caroline Diorio, MD, leads a panel to examine increased understanding of the biology of CAR T-induced toxicities.

February 5, 2026

Plenary session to examine latest advances to prevent GVHD

Brian Shaffer, MD, previews a session on cyclophosphamide, gut microbiota and T-cell depleted transplantation.
February 4, 2026

Welcome to the 2026 Tandem Meetings in Salt Lake City!

The leadership of ASTCT and CIBMTR outlines what to expect: cutting-edge science, inspiring speakers and being among those who share your dedication to transplantation, cellular therapy and better outcomes for all patients.
February 4, 2026

Session to provide essential updates on center-specific survival reporting

J. Douglas Rizzo, MD, MS, and Navneet Majhail, MD, MS, discuss plans for talks on obtaining and applying data.

MORE #TANDEM26 NEWS

February 5, 2026

Experts highlight the use of iPSC for transplant and gene therapy

Speakers detail novel studies and methods to reduce the need for patient- or donor-derived cells.
February 5, 2026

Panel to explore benefits and barriers of AI in cellular therapy

Panelist Wasay Khan, MD, PhD, explains why integrating artificial intelligence comes with hurdles.

February 5, 2026

Session to discuss the unique toxicities associated with CAR T

Chair Caroline Diorio, MD, leads a panel to examine increased understanding of the biology of CAR T-induced toxicities.
February 5, 2026

Plenary session to examine latest advances to prevent GVHD

Brian Shaffer, MD, previews a session on cyclophosphamide, gut microbiota and T-cell depleted transplantation.

AWARD SPOTLIGHTS

AWARD SPOTLIGHTS

MEET-THE-PROFESSOR SPOTLIGHTS